about
O-GlcNAcylation and Metabolic Reprograming in CancerTranscription factor Nrf1 is negatively regulated by its O-GlcNAcylation statusIdentification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression.High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylationBiosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerChanges in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.O-GlcNAcylation of the human epidermal growth factor receptor.Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.Interplay between protein glycosylation pathways in Alzheimer's disease.Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathwayInhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid.Augmented O-GlcNAcylation of AMP-activated kinase promotes the proliferation of LoVo cells, a colon cancer cell line.Polη O-GlcNAcylation governs genome integrity during translesion DNA synthesis.Electrophilic probes for deciphering substrate recognition by O-GlcNAc transferase.A Chemoenzymatic Histology Method for O-GlcNAc Detection.O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis.Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.Identification and Characterization of Complex Glycosylated Peptides Presented by the MHC Class II Processing Pathway in Melanoma.The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell DeathO-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1O-GlcNAc as an Integrator of Signaling PathwaysInvolvement of O-GlcNAcylation in the Skeletal Muscle Physiology and Physiopathology: Focus on Muscle Metabolism
P2860
Q27027028-927D07C3-334C-40DB-B5F7-486443BCAFCAQ28507099-43A2DE90-75FF-4646-A54C-4224696CE51BQ30252929-202C4505-A428-44B2-A1A3-640FEF5F9DF9Q34597312-94CA21EA-FCC6-4728-8DCA-6043E26CF128Q37305086-D303148A-DAA9-4F09-B390-20D01A53AD52Q37682200-243F8D2B-0AFE-440F-BA9A-670B4A8CCF8DQ38544783-A4BD79DF-94AA-4C99-A50F-249E15437C76Q38758695-F46E037B-6943-480A-8097-E5396DAD93BEQ38774452-0AA31347-99CD-4910-991F-4E9D03EC2E3CQ38860494-8D4D4A7C-F810-4264-B4F3-635460C06673Q39443781-C1388C6A-4FA7-4599-81BD-EBD8D12E6A9BQ41628456-83F5C166-E705-4290-9DF0-C4D86E26E82EQ41723383-D3243033-F808-44A7-A3B3-01E54CF59368Q42134504-C48D438B-BFC4-4AA9-A2DE-7952DEAD0D34Q42339288-F29D7D6C-D889-4C5A-B6AE-BD52C0D21B34Q45073732-51FD35E9-4B84-4D48-BAF6-212422C8646AQ47100126-4CC562F4-79C5-42D7-9321-AAB5AEAA450CQ47104269-E0099F1A-9108-4434-8522-2807CCE2DA0EQ47617036-27DA096B-F66D-41C5-B6B2-2CCAD55DE3B7Q47634187-9337C197-7DF2-47D2-940C-40B4888F177AQ47774103-BF0C75FF-A800-46E6-AE8A-86ED226B9D8AQ47999442-788A02EF-D68F-4DE4-AFCA-2323E7F58AD8Q50098159-205DC887-DAA9-4897-B79D-D736DCE6BBDDQ51556710-CC94D4F9-AC1F-4699-AFD6-55039386ADD1Q55497180-30A5480B-A011-4AF2-A03E-9CDA90088406Q57143658-D9857E04-6AB1-4134-9BEC-2AD2223ED4A4Q59078925-D6E71A9E-8DA9-4C2D-8F3E-186650139534Q59125594-DA32321D-21A8-4821-A0E6-1D88AF9504B2Q59127958-697F7BC3-BF43-454F-97C4-BC4C2E5B08AF
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
O-GlcNAcylation: The Sweet Side of the Cancer.
@ast
O-GlcNAcylation: The Sweet Side of the Cancer.
@en
type
label
O-GlcNAcylation: The Sweet Side of the Cancer.
@ast
O-GlcNAcylation: The Sweet Side of the Cancer.
@en
prefLabel
O-GlcNAcylation: The Sweet Side of the Cancer.
@ast
O-GlcNAcylation: The Sweet Side of the Cancer.
@en
P2860
P356
P1476
O-GlcNAcylation: The Sweet Side of the Cancer.
@en
P2093
Erika Carvalho
Rafaela Muniz de Queiroz
P2860
P356
10.3389/FONC.2014.00132
P577
2014-06-03T00:00:00Z